Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Anna Dewenter, Benno Gesierich, Anna Kopczak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Anna Dewenter, Benno Gesierich, Anna Kopczak, et al.
Stroke
|
March 18, 2022
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Family Members With a Pathogenic <i>NOTCH3</i> Variant Can Have a Normal Brain Magnetic Resonance Imaging and Skin Biopsy Beyond Age 50 Years
Remco J Hack, Gido Gravesteijn, Minne N Cerfontaine, et al.
Neurology
|
May 7, 2024
Association of <i>NOTCH3</i> Variant Risk Category With 2-Year Clinical and Radiologic Small Vessel Disease Progression in Patients With CADASIL
Minne N Cerfontaine, Remco J Hack, Benno Gesierich, et al.
Brain : a Journal of Neurology
|
December 19, 2022
Three-tiered EGFr domain risk stratification for individualized NOTCH3-small vessel disease prediction
Remco J Hack, Gido Gravesteijn, Minne N Cerfontaine, et al.
Annals of Clinical and Translational Neurology
|
November 16, 2016
Archetypal <i>NOTCH3</i> mutations frequent in public exome: implications for CADASIL
Julie W Rutten, Hans G Dauwerse, Gido Gravesteijn, et al.
Neuropathology and Applied Neurobiology
|
July 23, 2021
NOTCH3 variant position is associated with NOTCH3 aggregation load in CADASIL vasculature
Gido Gravesteijn, Remco J Hack, Aat A Mulder, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 10, 2026
NOTCH3 CADASIL Variant Receptor Aggregation Requires NOTCH3 Wild-Type Receptors: Identification of Highly Selective Inhibitors That Block the Process
Haijiang Wang, Xinxin Liu, Gido Gravesteijn, et al.
Annals of Clinical and Translational Neurology
|
January 19, 2019
Serum Neurofilament light correlates with CADASIL disease severity and survival
Gido Gravesteijn, Julie W Rutten, Inge M W Verberk, et al.
Stroke
|
July 21, 2022
Effect of <i>NOTCH3</i> EGFr Group, Sex, and Cardiovascular Risk Factors on CADASIL Clinical and Neuroimaging Outcomes
Remco J Hack, Minne N Cerfontaine, Gido Gravesteijn, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Anna Dewenter, Benno Gesierich, Anna Kopczak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Anna Dewenter, Benno Gesierich, Anna Kopczak, et al.
Stroke
|
March 18, 2022
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Family Members With a Pathogenic <i>NOTCH3</i> Variant Can Have a Normal Brain Magnetic Resonance Imaging and Skin Biopsy Beyond Age 50 Years
Remco J Hack, Gido Gravesteijn, Minne N Cerfontaine, et al.
Neurology
|
May 7, 2024
Association of <i>NOTCH3</i> Variant Risk Category With 2-Year Clinical and Radiologic Small Vessel Disease Progression in Patients With CADASIL
Minne N Cerfontaine, Remco J Hack, Benno Gesierich, et al.
Brain : a Journal of Neurology
|
December 19, 2022
Three-tiered EGFr domain risk stratification for individualized NOTCH3-small vessel disease prediction
Remco J Hack, Gido Gravesteijn, Minne N Cerfontaine, et al.
Annals of Clinical and Translational Neurology
|
November 16, 2016
Archetypal <i>NOTCH3</i> mutations frequent in public exome: implications for CADASIL
Julie W Rutten, Hans G Dauwerse, Gido Gravesteijn, et al.
Neuropathology and Applied Neurobiology
|
July 23, 2021
NOTCH3 variant position is associated with NOTCH3 aggregation load in CADASIL vasculature
Gido Gravesteijn, Remco J Hack, Aat A Mulder, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 10, 2026
NOTCH3 CADASIL Variant Receptor Aggregation Requires NOTCH3 Wild-Type Receptors: Identification of Highly Selective Inhibitors That Block the Process
Haijiang Wang, Xinxin Liu, Gido Gravesteijn, et al.
Annals of Clinical and Translational Neurology
|
January 19, 2019
Serum Neurofilament light correlates with CADASIL disease severity and survival
Gido Gravesteijn, Julie W Rutten, Inge M W Verberk, et al.
Stroke
|
July 21, 2022
Effect of <i>NOTCH3</i> EGFr Group, Sex, and Cardiovascular Risk Factors on CADASIL Clinical and Neuroimaging Outcomes
Remco J Hack, Minne N Cerfontaine, Gido Gravesteijn, et al.
Page
of 3